Suppr超能文献

使用Cas9和TALEN工程蛋白在啮齿动物受精卵中进行同源定向修复。

Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins.

作者信息

Ménoret Séverine, De Cian Anne, Tesson Laurent, Remy Séverine, Usal Claire, Boulé Jean-Baptiste, Boix Charlotte, Fontanière Sandra, Crénéguy Alison, Nguyen Tuan H, Brusselle Lucas, Thinard Reynald, Gauguier Dominique, Concordet Jean-Paul, Cherifi Yacine, Fraichard Alexandre, Giovannangeli Carine, Anegon Ignacio

机构信息

INSERM UMR 1064-ITUN; CHU de Nantes, Nantes F44093, France.

Platform Rat Transgenesis Immunophenomic, SFR François Bonamy, CNRS UMS3556 Nantes, F44093, France.

出版信息

Sci Rep. 2015 Oct 7;5:14410. doi: 10.1038/srep14410.

Abstract

The generation of genetically-modified organisms has been revolutionized by the development of new genome editing technologies based on the use of gene-specific nucleases, such as meganucleases, ZFNs, TALENs and CRISPRs-Cas9 systems. The most rapid and cost-effective way to generate genetically-modified animals is by microinjection of the nucleic acids encoding gene-specific nucleases into zygotes. However, the efficiency of the procedure can still be improved. In this work we aim to increase the efficiency of CRISPRs-Cas9 and TALENs homology-directed repair by using TALENs and Cas9 proteins, instead of mRNA, microinjected into rat and mouse zygotes along with long or short donor DNAs. We observed that Cas9 protein was more efficient at homology-directed repair than mRNA, while TALEN protein was less efficient than mRNA at inducing homology-directed repair. Our results indicate that the use of Cas9 protein could represent a simple and practical methodological alternative to Cas9 mRNA in the generation of genetically-modified rats and mice as well as probably some other mammals.

摘要

基于使用基因特异性核酸酶(如巨型核酸酶、锌指核酸酶、转录激活样效应因子核酸酶和CRISPRs-Cas9系统)的新型基因组编辑技术的发展,转基因生物的产生发生了革命性变化。产生转基因动物最快速且最具成本效益的方法是将编码基因特异性核酸酶的核酸显微注射到受精卵中。然而,该程序的效率仍可提高。在这项工作中,我们旨在通过将TALENs和Cas9蛋白(而非mRNA)与长或短的供体DNA一起显微注射到大鼠和小鼠受精卵中,来提高CRISPRs-Cas9和TALENs同源定向修复的效率。我们观察到,Cas9蛋白在同源定向修复方面比mRNA更有效,而TALEN蛋白在诱导同源定向修复方面比mRNA效率更低。我们的结果表明,在产生转基因大鼠和小鼠以及可能的其他一些哺乳动物时,使用Cas9蛋白可能是一种简单实用的方法,可替代Cas9 mRNA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eecf/4595769/933ea671131b/srep14410-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验